Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Revenue	$ 119,156	[1]	$ 48,087	[2]	$ 27,371	[3]
Costs and operating expenses:
Research and development	11,821		6,720		3,168
Sales and marketing	14,006		6,413		4,701
General and administrative	32,448		14,607		8,893
Intangible asset amortization	8,202		3,033		1,079
Acquisition costs	1,636		668		940
Change in fair value of contingent consideration	2,875		1,575		50
Total operating expenses	153,096		53,662		27,591
Operating loss	(33,940)		(5,575)		(220)
Other income (expense):
Change in fair value of warrant liability	(121)		3,601		(12,835)
Change in fair value of investments	0		1,319		0
Interest (expense) income, net	(432)		58		501
Other income (expense)	289		0		(13)
Total other income (expense), net	6,187		4,978		(2,978)
Loss before income tax benefit	(27,753)		(597)		(3,198)
Income tax benefit	20,118		3,264		1,541
Net (loss) income	(7,635)		2,667		(1,657)
Net (loss) income attributable to common shareholders:
Basic	(7,635)		2,450		(1,657)
Diluted	$ (7,635)		$ (954)		$ (1,657)
Basic (in dollars per share)	$ (0.20)		$ 0.09		$ (0.09)
Diluted (in dollars per share)	$ (0.20)		$ (0.03)		$ (0.09)
Weighted average shares used to compute (loss) earnings per share attributable to common shareholders:
Basic and Diluted (in shares)	38,503,944		27,306,258		19,460,299
SAVSU [Member]
Other income (expense):
Gain on acquisition	$ 0		$ 0		$ 10,108
Sexton Biotechnologies, Inc. [Member]
Other income (expense):
Gain on acquisition	6,451		0		0
SAVSU [Member]
Other income (expense):
Loss from equity-method investment in SAVSU	0		0		(739)
Product [Member]
Revenue	101,913		44,540		26,844
Costs and operating expenses:
Cost of goods and services	69,676		18,058		8,355
Service Revenue [Member]
Revenue	9,817		1,752		0
Costs and operating expenses:
Cost of goods and services	5,381		1,367		405
Rental Revenue [Member]
Revenue	7,426		1,795		527
Costs and operating expenses:
Cost of goods and services	$ 7,051		$ 1,221		$ 0

[1] 2021 revenue includes product revenue related to Global Cooling from May 3, 2021 through December 31, 2021 and product revenue related to Sexton from September 1, 2021 through December 31, 2021.

[2] 2020 revenue includes service revenue related to SciSafe from October 1, 2020 through December 31, 2020.

[3] 2019 revenue includes product revenue related to Astero Bio Corporation ("Astero") from April 1, 2019 through December 31, 2019; rental revenue related to SAVSU from August 8, 2019 through December 31, 2019; and product revenue related to CBS from November 12, 2019 through December 31, 2019.